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Radiofrequency Exposure and
Human Cancers: Elwood's
Response
I thank Hocking for his interest in my
review (1). In regard to his own study (2), I
put more emphasis on the incidence than
the mortality results for several reasons.
The interpretation of the mortality results
is more complex, requiring control for con-
founding by prognostic factors (such as
stage at diagnosis and precise age) as well as
by risk factors for incidence. The difference
between the relative risks for incidence and
for mortality is not statistically significant,
and ofcourse the two results are not inde-
pendent. The incidence results are also
more useful because they can be compared
with those ofanother study. The discussion
in the paper by Hocking et al. (2) is almost
all on the incidence relationship. The sug-
gestion that radiofrequency radiation
(RFR) exposure is related to adverse sur-
vival is a new hypothesis generated from
these results and, as far as I know, has not
been assessed in other studies.
The comparison of the two studies of
childhood leukemia in Sydney, Australia
(2-4), involves a comparison of concepts.
In his letter, Hocking claims that the origi-
nal hypothesis for these studies was that the
leukemia rate in the three areas close to the
TV towers would be different from the rate
in the six areas farther away; as stated in my
review (1), his statistical analysis depends on
this comparison. However, in my opinion,
the original hypothesis is epidemiological-
whether there is an increased cancer inci-
dence (and mortality) in children exposed
to RFR from TV towers; this is given as the
objective in the first paper by Hocking et al.
(2). The use ofa statistical design that com-
pares two sets of areas is one way to assess
this. This approach is not unreasonable but
ignores the information provided by the
comparison of each individual area. Such
data are relevant to the assessment of the
consistency of any association, which is an
important aspect in assessing causality. I was
surprised that the results by individual
municipality, which Hocking et al. had
available, were not given in the original
paper (4), as I believe they affect the inter-
pretation. The subsequent analysis showed
that the excess was seen in only one of the
three areas close to the TV towers (3).
Because of statistical variability, this does
not rule out the general association seen by
Hocking et al., but it shows inconsistency
and weakens the argument that the associa-
tion seen is caused by RFR from the TV
towers rather than from anyother cause.
In the Polish military study (5), the
published report states that information on
possible carcinogenic factors and RFR expo-
sure was available for cancer cases from hos-
pital records, in addition to data from other
sources available for all personnel. This rais-
es the possibility ofsystematic bias, as some
information on exposure is available only
for affected subjects. This potential bias has
been noted independently in another
detailed epidemiologic review (6). In regard
to the U.S. Navy study (7), Hocking
emphasizes the majorweakness ofthe study,
which I have noted. I agree that this study is
very limited in exposure information.
In the case-control study ofbrain can-
cers, Thomas et al. (8) found a significant
excess risk in electronics workers with no
exposure to RFR, and no excess risk in
those exposed to RFR who were not elec-
tronics workers. There was an increased
risk in electronics workers who were also
exposed to RFR, but this risk was lower
than the risks for all electronics workers.
Although this may be consistent with some
complex promotional effect, the more par-
simonious explanation is that the increased
risk in electronics workers is due to some
exposure other than RFR.
In his letter, Hocking refers to a New
Zealand environment court case (9) that
concerned a proposed Telecom cell phone
transmitter site near a school. I appeared as
an expert witness for Telecom, and he
appeared as a witness for the school. My
published review (1) was developed at the
same time as my written evidence, but was
not submitted until after the case in order
to benefit from legal review as well as from
scientific peer review. The legal hearing has
resulted in a detailed judgment in favor of
Telecom (9). In his judgment, Judge
Jackson commented on each of the several
expert witness submissions. He noted that
"Elwood's evidence was carefully construct-
ed and balanced" (y.
In summary, although the points raised
by Hocking are worthy of note, I do not
agree that any of them represent "impor-
tant omissions" in my review paper.
J. MarkElwood
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Comments on "What Is a
Tumor Promoter?"
In the August issue of Environmental
Health Perspectives, Raymond Tennant (1).
shared his
perspective on how the identification of tumor
promotion relates to the assessment of human
health risk from environmental carcinogens.
I would like to reply to several ofhis state-
ments. Although a complete reanalysis of
his perspective is beyond this letter, I rec-
ommend additional reading (2-6). My
comments are based on looking at the mul-
tistep, multimechanism process of carcino-
genesis from a completely different para-
digm, based on different assumptions.
Tennant (1) states that
The role ofthe tumor-promoting agents has not
been so specifically defined, even in the most
well-studied mouse skin model.
It has been known for over 20 years that a
testable hypothesis exists, based on a specif-
ic cellular mechanism; this hypothesis is
supported by data derived from molecular
oncological, biochemical, cellular, and now
knockout mouse data (2,7). This mechanis-
tic model, namely, the reversible inhibition
of gap junctional intercellular communica-
tion (GJIC), is as complete, ifnot more so,
than our detailed mechanistic understand-
ing of "initiation," which is assumed to be
related to DNA damage and mutagenesis.
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Tennant (1) stated that "... few, if any,
DNA reactive or genotoxic substances are
only tumor initiators." Here, an assumption
is being made that the DNA reactive or
genotoxic substance [determined in an
imperfect assay, such as the Ames test, sister
chromatid exchange, thymidine kinase
minus, hypoxanthine-guanine phosphoribo-
syltransferase, comet, micronucleus, and
unscheduled DNA synthesis assays (8-11)]
is, in fact, genotoxic. Even if an agent can
damage DNA and lead to a mutation, the
agent can cause cell death at significant expo-
sures. Cell death can then lead to compen-
satory hyperplasia of the surviving cells. In
addition, not all cytotoxic agents or hyper-
plastic-inducing conditions (burned tissue,
surgery, etc.) damage DNA or cause muta-
tions. There is an argument that these hyper-
plastic conditions cause mutations indirectly
by causing surviving cells with nonlethal
DNA lesions to have mutations fixed by'
DNA replication. Although in principle this
is possible, it does not explain the fact that
animals can be exposed to DNA-damaging
agents, but promoted months later, after the
DNA has been repaired. In addition,
Tennant ignored the fact that spontaneously
initiated cells exist in all organisms.
Therefore, an agent that kills cells or acts as a
mitogen, but is not a mutagen, could pro-
mote a previously existing spontaneously ini-
tiated cell. This could provide an alternative
explanation to Tennant's statement that
long-term repetitive treatment with either
DNA reactive or nonreactive substances can
result in the initiation/promotion and pro-
gression oftumors. The fact that "for the vast
majority of substances that are carcinogenic,
repetitive exposures are required," supports
my contention that most ofthe so-called car-
cinogens (tested at high doses and for long
periods of time) are, in fact, not true muta-
gens. Most are nongenotoxic, epigenetic sub-
stances. These substances are false positives in
insensitive genotoxic assays or because the
artifacts are ignored in these assays; this leads
to the substances being misidentified as
mutagens (8-11).
Tennant's (1) third assumption is that
initiation or induction ofmutations occurs in
"appropriate target cells." Although I agree
that carcinogenesis is the result of a small
population oftarget cells being susceptible to
neoplastic transformation (the pluripotent
stem cells) (7,12), this has implications relat-
ed to the necessity of some chemicals to be
metabolized into electrophiles in order to
damage DNA and induce mutations. When
a rat is fed a chemical and a biochemist/mol-
ecular biologist grinds up a liver, extracts
DNA, and searches for DNA lesions, he/she
will find them. However, the heparocytes
(those cells with the drug-metabolizing
enzymes) make up the greater portion ofthe
DNA being analyzed. Only a few ofthe cells
in the liver are the target or stem cells.
Therefore, extrapolating from the exquisite
molecular analyses of DNA lesions from
nontarget cells to the tumor in the animal fed
a chemical does not prove the chemical
caused the mutation in an oncogene/tumor-
suppressor gene found in the rat tumor.
Tennant did not mention the hypothesis
ofGJIC inhibition oftumor promotion. This
hypothesis is based on the operational obser-
vation of the action of promoters in vivo;
namely, promoters must be given after the
initiation (hours, days, weeks, months, or in
the case of humans, presumably years), con-
sistently exceeding no-effect or threshold lev-
els for extended periods. The early steps of
promotion are reversible or interruptible. This
cannot be explained by any mutagenic or irre-
versible process ascribed to initiators.
Mutagenic events are, for practical purposes,
irreversible. Promoters must lead to the clonal
multiplication ofthe single initiated cell. This
clonal expansion ofinitiated cells is the result
ofboth a mitogenic process due to an increase
in the birth ofnew cells and the prevention of
the death ofinitiated cells [inhibition ofapop-
tosis (13)]. Normal quiescent or GO cells are
contact inhibited (14). Tumor promoters
release cells from contact inhibition by involv-
ing the inhibition ofGJIC (15).
I take issue with Tennant's statement (1)
that
...there is nio information suLch as chemical struc-
ture or in vitro effects to reliabh predict potential
nion-DNA reactive carcinogetns.
There are many papers [including studies of
DDT, dieldrin, polybrominated biphenyls,
polychlorinated biphenyls, dinitrofluoroben-
zene, pentachlorophenol, etc. (16-18)] that
predicted the tumor-promoting activity in
vitro using the GJIC assay before testing in
vivo. Moreover, more recent papers have, in
fact, shown structure-function relationships
that correlate inhibition of GJIC and tumor
promotion (19-21).
Finally, I have a few comments related to
the use ofgenetically modified mice and the
DNA microarray technology. The connexin
32 knockout mouse may be the best model
to search for tumor initiators of the rat liver
because the mouse is a constitutive promoter
(22) and because it has lost one ofits tumor-
suppressing genes. The use ofDNA microar-
ray technology to identify genes associated
with non-DNA reactive carcinogens may be
likened to closing the barn door after the
horses have escaped. Some tumor-promoting
chemicals can inhibit GJIC very early (min-
utes), induce signal transduction, posttransla-
tionally modify proteins (p53), alter gene
expression, induce DNA synthesis, and lead
to cell proliferation in the few target cells.
Studying gene expression profiles in normal
tissues (with few stem cells, more progenitor
cells, and many terminally differentiated
cells, all in different stages of the cell cycle
and all expressing different genes, and a few
apoptotic cells) and comparing treated or dis-
eased tissues (with each cell type in different
stages ofthe cell cycle and wvith different reac-
tions to a given chemical) will generate bewil-
dering patterns of gene expression, most of
which will not reflect what goes ot in the few
target cells.
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Tumor Promoters: Tennant's
Response
Trosko indeed presents an alternative and
valid position on the nature of tumor pro-
motion. It is certainly true that disrupted
intracellular communication is an important
component in the promotion and develop-
ment of tumors and may be another path-
way by which repetitive exposure to
nongenotoxic carcinogens and genotoxic
carcinogens results in altered heritable cell
phenotypes. The editorial in EHP (1) was
not meant to be an exhaustive catalog ofall
of the various mechanisms by which
nongenotoxic carcinogenesis can occur. It is
clear that intercellular and intracellular sig-
naling via endocrine, exocrine, paracrine,
and autocrine pathways is critical in main-
taining phenotypic stability. Evidence also
suggests that when gap junctional intracellu-
lar communication pathways are disrupted,
the frequent consequence is altered gene
expression. Preliminary experiments (Z do
not suggest that exposure of skin to
nongenotoxic carcinogens or to a tumor
promoter results in a bewildering pattern of
changes in gene expression. We believe that
it is plausible that analysis of time-depen-
dent changes in the pattern ofgene expres-
sion will provide an understanding of cell-
signalingpathways that are altered bychemi-
cal exposure. It may also result in the recog-
nition ofbiomarkers ofcritical events in the
neoplastic process thatwill include disrupted
gapjunctional communication.
RaymondTennant
NIEHS
ResearchTriangle Park, North Carolina
E-mail: tennant@niehs.nih.gov
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CORRECIONAND LARICATN
In the November EHPnet article
"Connecting for Kids" [EHP 107:A553],
we wrote of the Children's Environ-
mental Health Network (CEHN):
"Currendy, this public interest organiza-
dion is lobbying the U.S. Environmental
Protection Agency (EPA) to require test-
ing ofpesticides for their effects on the
developing nervous systems ofchildren."
Although the CEHN is an advocacy
group, itdoes notlobbyspecific pieces of
legislation. EHP regrets any confusion
thiswordingmayhave caused.
The.Iatestword~onienvuonment lhealth ~iL &.::. .. ....fi n g e rt..p s.
r~~~~~~~~~~~~~~~~~~~~~~~~~~..........._.,1..
,e S |S| _ vX nforation Se ~~~~~~~~~~~~~~~~rcal'_80
~~~~~~~~~~~~~~~~~~u~~~~~~~~~~~~~~~~..i... .
Environmental Health Perspectives * Volume 107, Number 12, December 1999 A 599